Galmed develops brain-penetrating nanoparticle Aramchol for Parkinson’s, co-developed with Barcode Nanotech, plans PoC Ph1b/2 PD trial in H2 2026
https://finviz.com/quote.ashx?t=GLMD&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.